ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETF vs Bajaj Finserv Healthcare Fund

ABSL vs Bajaj· Portfolio Overlap Analysis

50.7%High Overlap
14 common stocksRank #9374 / 20,000

Investor takeaway: At 50.7% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.

Common Holdings (14)

StockWt% in ADITYA BIRLA SUN LIFE NIFTY HEWt% in Bajaj Finserv HealthcareOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
18.36%8.40%8.40%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
8.13%9.21%8.13%
Apollo Hospitals Enterprise Limited
Healthcare Services
8.04%6.80%6.80%
Torrent Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
4.52%5.46%4.52%
Max Healthcare Institute Limited
Healthcare Services
8.11%4.40%4.40%
Fortis Healthcare Limited
Healthcare Services
4.90%3.60%3.60%
Aurobindo Pharma Limited
Pharmaceuticals & Biotechnology
3.41%5.93%3.41%
Lupin Limited
Pharmaceuticals & Biotechnology
5.57%2.65%2.65%
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
2.12%2.45%2.12%
Glenmark Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
3.21%1.88%1.88%
Biocon Limited
Pharmaceuticals & Biotechnology
2.78%1.42%1.42%
Abbott India Limited
Pharmaceuticals & Biotechnology
1.38%1.46%1.38%
Cipla Limited
Pharmaceuticals & Biotechnology
7.57%1.02%1.02%
Piramal Pharma Ltd
Pharmaceuticals & Biotechnology
0.96%6.21%0.96%

Unique to ADITYA BIRLA SUN LIFE NIFTY HE

  • Dr. Reddys Laboratories Limited7.82%
  • Laurus Labs Limited4.17%

Unique to Bajaj Finserv Healthcare

  • Emcure Pharmaceuticals Limited3.79%
  • Rubicon Research Limited3.70%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
35.9% (11)
Healthcare Services
14.8% (3)

More comparisons for ADITYA BIRLA SUN LIFE NIFTY HE

More comparisons for Bajaj Finserv Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.